Corn Succotash and Corn & Black Bean Salsa recipes
(Photo Credit: KDKA)
Corn Succotash
3 ears corn, grilled and cooled
12 oz lima beans (or edamame)
3 Tbsp olive oil
1 lemon, juiced
1 garlic clove, minced
1 tsp kosher salt
1/2 tsp black pepper
1 pint grape or cherry tomatoes, halved
2 scallions, thinly sliced
4 slices bacon, cooked and crumbled (optional)
Using a large bowl and a small cup set upside down, carve down the cob to remove the kernels. *Freeze the cobs to use in a vegetable stock.
Combine the rest of the ingredients in the bowl. Can be served hot, cold or at room temperature. Lasts in the fridge for up to a week.
Corn & Black Bean Salsa
4 ears fresh corn, grilled or steamed
15 oz can black beans, drained/rinsed
1/2 of a red bell pepper, diced
1/2 tsp garlic powder
1 lime, zested and juiced
1 Tbsp cilantro (or parsley), minced
2 Tbsp olive oil
1/2 tsp salt
1/4 tsp pepper
1 jalapeno (or banana pepper), minced (optional)
Using a large bowl and a small cup set upside down, carve down the cob to remove the kernels. *Freeze the cobs to use in a vegetable stock.
Combine the rest of the ingredients in the bowl. Can be served hot, cold or at room temperature. Lasts in the fridge for up to a week.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
19 minutes ago
- Washington Post
Carolyn Hax: Physical 5-year-old roughhouses right through parental warnings
Adapted from an online discussion. Hi Carolyn! I have a 5-year-old, 'Jane,' and a 2-year-old. Jane is a highly physical kid and loves to roughhouse. She also ALWAYS is chewing on things that aren't food. There have been times recently where she has hurt herself doing something that I've already warned her not to do and inside I'm just screaming, 'I told you so!'
Yahoo
39 minutes ago
- Yahoo
Warren Buffett's Berkshire Hathaway Just Bought Into Beaten-Down UnitedHealth. Should Investors Follow Suit?
Key Points Warren Buffett and a few other high-profile investors bought UnitedHealth stock in Q2. The company has been struggling after it did a poor job of forecasting medical cost trends. However, it should have a clear path to fixing some of the issues it is facing. 10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) has run into a very difficult stretch, with the stock price cut nearly in half over the past year. However, a few well-known investors scooped up shares of the stock in the second quarter, including Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Buffett, through Berkshire, bought more than 5 million shares of the managed care company, worth an estimated $1.6 billion. Meanwhile, Michael Burry, who became famous in the book and movie The Big Short for his bet against subprime mortgages, bought 20,000 shares. Billionaire David Tepper also increased his stake in the name during the quarter. Let's see what these investors see in the struggling health insurance provider. UnitedHealth got caught up in a pricing misstep The biggest issue facing UnitedHealth is the mismatch between how the company priced its health plans and the actual medical costs it is paying out. According to the company, it's expecting to pay out an incredible $6.5 billion more in medical costs than it initially planned for 2025. A big chunk of that -- around $3.6 billion -- is tied to its Medicare plans, which it said are facing a "generational pullback in Medicare funding" that's been in motion for a couple of years. These cost pressures, unfortunately for the company, aren't just hitting one part of its business, though. While Medicare has been the biggest problem, its commercial business has also been under pressure, split evenly between its Affordable Care Act (ACA) and employer businesses. In addition, it's also seeing pressure with Medicaid, particularly when it comes to behavioral health. In its Medicare Advantage segment, UnitedHealth has been seeing care activity, particularly from physician and outpatient services, come in significantly higher than it expected. It initially assumed a Medicare Advantage medical cost trend of just over 5%, but now it expects the actual number to be closer to 7.5% this year. A large part of this appears to be from patients going to the emergency room more frequently, and ERs increasing observational stays and bundling more services as part of these visits. Meanwhile, its OptumHealth division, which is its health service and technology arm, is struggling with its value-based care business. The company said OptumHealth's earnings this year are on track to come in a whopping $6.6 billion below expectations. It said there were three main reasons for this underperformance. The first is its mix in enrollment, as new members who were previously underserved have more complex issues than expected. Second, it's been seeing accelerated medical trends, especially in areas like outpatient procedures and behavioral health. And finally, it underestimated the risk of the new members it added. To try to shift the current tide, UnitedHealth has made significant leadership and operational changes that are focused on improving its clinical and billing systems. The company plans to adjust its pricing strategy for 2026, as it expects that these elevated medical cost trends will continue. The company will also lean into artificial intelligence (AI) to try to increase efficiency, reduce costs, and improve forecasting. Is UnitedHealth stock a buy? While UnitedHealth is going through a rough stretch, the company should be able to turn its business around. The first step is adjusting its pricing to better reflect medical trends when its annual contracts come up for renewal. With the advent of AI, it should be easier now than ever to forecast trends and price accordingly. However, pricing is not the sole fix, and if it sets prices too high, it can also lose members to lower-cost plans. Meanwhile, with Medicare, it can't just increase prices; it must justify any annual price increases as part of its bid to the Centers for Medicare and Medicaid Services (CMS). Meanwhile, CMS will set a benchmark price based on its formula, and then any plans with bids above the benchmark would have to charge a premium to customers above the benchmark price. So while in theory it can increase Medicare pricing, pricing its plan above the benchmark could lead to low enrollment. As such, the company also needs to work on changing patient behavior. Way too many people are using the ER as their primary physician, and hospitals appear to be leaning into this, adding services to increase costs that they then bill to the insurance company. This is a systemic issue impacting the whole U.S. healthcare system, but if UnitedHealth can find a way to incentivize members to use telehealth or urgent care, it could go a long way in helping to keep medical costs down. Repricing some plans should lead to a quick improvement, while changing consumer behavior will take longer. However, I think the worst should be over for UnitedHealth this year. As such, with the stock cut in half and trading at a forward price-to-earnings (P/E) ratio of 16 times 2026 analyst estimates, I think investors can look to follow Buffett and these other well-known investors into the stock. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Warren Buffett's Berkshire Hathaway Just Bought Into Beaten-Down UnitedHealth. Should Investors Follow Suit? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
40 minutes ago
- Yahoo
UnitedHealth's Push Into Home Health: A New Growth Chapter?
UnitedHealth Group Incorporated UNH is making a significant move in home health as the next frontier of care delivery. With the help of its Optum division, the company is further diving into home-based care, focusing on offering treatment in a more comfortable and affordable environment for patients. It aims to reduce hospital admissions, enhance chronic condition management and improve patient satisfaction, which plays a crucial role in shaping outcomes and managing costs. UNH's previous acquisition of LHC Group and recent acquisition of Amedisys demonstrate its dedication to this space. Followed by months of regulatory scrutiny, the companies agreed to divest 164 home health and hospice facilities across 19 states to proceed with the $3.3 billion acquisition of Amedisys. This initiative is a bold jump toward value-based care. It also strengthens its relationship with members. This move will likely boost revenues and increase the number of people served while bringing costs down. The company expects the number of patients served by the fully accountable value-based care model to increase to 5 million in 2025. In the first half of 2025, UNH reported 5.8% year-over-year growth in revenues in its Optum business. We expect the metric to rise 5.7% year over year in 2025. Home health is gradually evolving as a key component of UNH's long-term strategy as the U.S. population is aging, which results in an increase in demand for in-home care. How Are Competitors Faring? Some of UNH's major competitors in the value-based care space are Elevance Health, Inc. ELV and Humana Inc. HUM. Elevance Health's care delivery services primarily focus on serving chronic and complex populations by offering tailored care in the home and virtually. Elevance Health acquired CareBridge in 2024, which provides virtual care to Medicaid and Medicare patients and helps in plans in managing home and community-based services. Humana's CenterWell business offers services like pharmacy, primary care and home health solutions, which are designed to improve the overall healthcare experience. Humana's revenues from the CenterWell unit rose 8.9% year over year in the first half of 2025. UnitedHealth's Price Performance, Valuation & Estimates Shares of UNH have declined 39.9% in the year-to-date period compared with the industry's fall of 31.6%. Image Source: Zacks Investment Research From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 17.35, above the industry average of 14.63. UNH carries a Value Score of B. Image Source: Zacks Investment Research The Zacks Consensus Estimate for UnitedHealth's 2025 earnings is pegged at $16.58 per share, implying a 40.1% drop from the year-ago period. Image Source: Zacks Investment Research The stock currently carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Humana Inc. (HUM) : Free Stock Analysis Report Elevance Health, Inc. (ELV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
